URGN compared with IMTX: revenue, margins and what each company keeps, and the suppliers and customers both name

URGNUroGen Pharma Ltd.

Mkt capRevenueRevenue

IMTXImmatics N.V.

Mkt capRevenueRevenue

Compare

URGNUroGen Pharma Ltd.

IMTXImmatics N.V.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only URGN 6

AGENAgenussupplier

TEVATeva Pharmaceuticals Industriessupplier

—Cenexi-Laboratories Thissenunlistedsupplier

—IconOVir Biounlistedsupplier

2 more · URGN chain ›

Shared 0

No shared counterparties.

Only IMTX 2

BMYBristol-Myers Squibbcustomer

MRNAModernaTXcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

URGNUroGen Pharma Ltd.

24.77▼−3.72%· post 24.38

Mkt cap$1.2BRevenue$89MQ3 FY26Revenue$110MFY25

IMTXImmatics N.V.

6.34▲+2.65%· post 6.34

ClosedNov 6 '26

Mkt cap$852.7MRevenue—Revenue—

Compare

ClosedNov 6 '26

URGNUroGen Pharma Ltd.

IMTXImmatics N.V.

24.77▼−3.72%post 24.38

Price

6.34▲+2.65%post 6.34

$1.2B

Mkt cap

$852.7M

Q3 FY26$89M

Revenue

—

FY25$110M

Revenue

—

URGN24.77▼−3.72%vsIMTX6.34▲+2.65%ClosedNov 6 '26